[go: up one dir, main page]

OA09247A - "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés". - Google Patents

"Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés".

Info

Publication number
OA09247A
OA09247A OA59691A OA59691A OA09247A OA 09247 A OA09247 A OA 09247A OA 59691 A OA59691 A OA 59691A OA 59691 A OA59691 A OA 59691A OA 09247 A OA09247 A OA 09247A
Authority
OA
OAPI
Prior art keywords
compounds
furo
enantiomers
pyridine
preparation
Prior art date
Application number
OA59691A
Other languages
English (en)
French (fr)
Inventor
Bonato Marc
Eck Charles
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of OA09247A publication Critical patent/OA09247A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
OA59691A 1988-04-06 1989-12-10 "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés". OA09247A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives

Publications (1)

Publication Number Publication Date
OA09247A true OA09247A (fr) 1992-06-30

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59691A OA09247A (fr) 1988-04-06 1989-12-10 "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés".

Country Status (28)

Country Link
US (1) US5026855A (fi)
EP (1) EP0337858B1 (fi)
JP (1) JP2680456B2 (fi)
KR (1) KR970005308B1 (fi)
AT (1) AT397093B (fi)
AU (1) AU616753B2 (fi)
BE (1) BE1003843A4 (fi)
CA (1) CA1338475C (fi)
CH (1) CH680000A5 (fi)
DK (1) DK167020B1 (fi)
DZ (1) DZ1335A1 (fi)
ES (1) ES2057159T3 (fi)
FI (1) FI93116C (fi)
FR (2) FR2629820B1 (fi)
GB (2) GB8808001D0 (fi)
IE (1) IE61915B1 (fi)
IN (1) IN172987B (fi)
MA (1) MA21529A1 (fi)
MY (1) MY104424A (fi)
NL (1) NL8920307A (fi)
NZ (1) NZ228614A (fi)
OA (1) OA09247A (fi)
PT (1) PT90210B (fi)
SE (1) SE509130C2 (fi)
SG (1) SG40492G (fi)
TN (1) TNSN89043A1 (fi)
WO (1) WO1989009772A1 (fi)
ZA (1) ZA892477B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20050113314A1 (en) * 2003-08-29 2005-05-26 Fong Benson M. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
US20080312241A1 (en) * 2007-01-03 2008-12-18 Gilead Sciences, Inc. Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2011043914A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (fi) * 1981-02-10 1985-11-09 Scras
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
IN160104B (fi) * 1983-04-05 1987-06-27 Scras
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
GB2235194B (en) 1992-01-29
NL8920307A (nl) 1990-03-01
ATA900589A (de) 1993-06-15
JPH02504394A (ja) 1990-12-13
NZ228614A (en) 1990-11-27
KR900700483A (ko) 1990-08-13
ES2057159T3 (es) 1994-10-16
KR970005308B1 (ko) 1997-04-15
FI93116C (fi) 1995-02-27
FI895826A0 (fi) 1989-12-05
IE891076L (en) 1989-10-06
BE1003843A4 (fr) 1992-06-30
GB2235194A (en) 1991-02-27
EP0337858A1 (fr) 1989-10-18
GB8808001D0 (en) 1988-05-05
WO1989009772A1 (fr) 1989-10-19
US5026855A (en) 1991-06-25
IE61915B1 (en) 1994-11-30
PT90210B (pt) 1994-06-30
ZA892477B (en) 1989-12-27
CA1338475C (en) 1996-07-23
FR2629821B1 (fr) 1993-12-03
IN172987B (fi) 1994-01-15
SE509130C2 (sv) 1998-12-07
MY104424A (en) 1994-03-31
TNSN89043A1 (fr) 1991-02-04
DK167020B1 (da) 1993-08-16
CH680000A5 (fi) 1992-05-29
EP0337858B1 (fr) 1994-06-08
SE8904104D0 (sv) 1989-12-05
AU3419089A (en) 1989-11-03
MA21529A1 (fr) 1989-12-31
FR2629821A1 (fr) 1989-10-13
AT397093B (de) 1994-01-25
JP2680456B2 (ja) 1997-11-19
FR2629820B1 (fr) 1993-12-03
PT90210A (pt) 1989-11-10
FR2629820A1 (fr) 1989-10-13
DK611689D0 (da) 1989-12-05
SE8904104L (sv) 1989-12-05
DZ1335A1 (fr) 2004-09-13
DK611689A (da) 1989-12-05
GB8927509D0 (en) 1990-06-13
AU616753B2 (en) 1991-11-07
FI93116B (fi) 1994-11-15
SG40492G (en) 1992-06-12

Similar Documents

Publication Publication Date Title
OA09247A (fr) "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés".
OA07947A (fr) Nouveaux dérivés de la furo-(3,4-c)-pyridine substitués en position 6, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés.
OA09387A (fr) "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
OA07864A (fr) Nouveaux dérivés de la vinyl-6 furo-(3,4-c) -pyridine leur préparation et compositions pharmaceutiques à base de ces composés.
DZ1758A1 (fr) Procédé pour la préparation d'aryl-piperidine carbinols.
DZ1414A1 (fr) Dérivés de la thiéno-triazolo-diazépine, ainsi qu'un procédé de préparation desdits composés.
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
EP0657438A3 (en) Process for the preparation of alkylsulfinylbenzamides and 1,2-benzisothiazol-3-ones.
EP0685491A3 (en) Process for producing albumin preparation.
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
OA08172A (fr) Nouveaux dérivés de la thiénopyridine, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés.
OA09201A (fr) "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant".
OA07840A (fr) Dérivés de la chloro-4-furo-(3,4-c)-pyridine, leur procédé de préparation et compositions thérapeutiques à base de ces dérivés.
OA08125A (fr) Nouveaux dérivés de la pyridine, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés.
OA06690A (fr) Composés d'amino-thiadiazolyle, procédé pour leur préparation.
FR2623501B1 (fr) Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
OA08416A (fr) Nouveaux dérivés du catéchol, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés.
OA09903A (fr) Dérivés de la Benzofuranylimidazol, leur procédé de préparation ainsi qu'une composition thérapeutique les contenant.
MA20491A1 (fr) Procede de preparation d'aminomethylene-2 indanedione-1,3 substituees sur l'azote
HK47392A (en) Stereospecific process for the preparation of furo(3,4-c)pyridine enantiomers,compounds thus obtained and therapeutical compositions thereof
FR2712594B1 (fr) Procédé de préparation de l'oenotheine B à partir d'Epilobium Parviflorum.
BE1002101A4 (fr) Procede pour la preparation de derives d'as-triazine condenses et composes obtenus.
FR2695123B1 (fr) Procédé pour la préparation de composés éthaniques fluorés.